Highlights
NASDAQ: AVXL       Anavex Lf SC
Last Price Today's Change   Day's Range   Trading Volume
2.48   +0.08 (3.33%)  2.41 - 2.50  258,500

Overview

 
Avg Volume (4 weeks):307,065
4 Weeks Range:2.30 - 2.96
4 Weeks Price Volatility (%):
27.27%
52 Weeks Range:1.25 - 4.09
52 Weeks Price Volatility (%):
43.31%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company operating in the United States. It is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including drug candidates to treat Alzheimer's disease, other central nervous systems (CNS) diseases, pain and several types of cancer. The lead compound of the company is ANAVEX 2-73 which is developed to treat Alzheimer's disease, Parkinson's disease and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome. The research and development pipeline of the company includes one clinical drug candidate and several compounds in various stages of the pre-clinical study.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers